CYTK:NASDAQ
Cytokinetics, Inc.
$64.29
arrow_upward
+0.53%(+0.34) 1D
Oct 21, 10:07:05 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$64.30
High
$64.78
Low
$63.90
Mkt. cap
8.94B
Avg. vol.
2.09M
Volume
54.56K
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
Open
$64.30
High
$64.78
Low
$63.90
Mkt. cap
8.94B
Avg. vol.
2.09M
Volume
54.56K
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
Investing.com UK
·
8 hours ago
Form 144 CYTOKINETICS For: 21 October By Investing.com
Investing.com UK
·
8 hours ago
Cytokinetics EVP Fady Malik sells over $224,000 in stock By Investing.com
Investing.com UK
·
17 hours ago
Form 4 Cytokinetics Inc: Nancy Wysenski (Director) For: 16 October By Investing.com
Stock Titan
·
17 hours ago
A 195-share award brings Harrington's direct Cytokinetics (CYTK) holdings to 22,127 shares.
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com